An observational study in Healthy and Glaucoma, sponsored by Optovue. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-06-10.
Sponsored by Optovue · Observational
To perform a clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology.
Clinical validation study of RTVue features in volunteers with various ocular pathology or no ocular pathology. Subjects to undergo a clinical exam and OCT scanning.
1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.
This study's enrollment of 53 is below the median of 103 across 454 observational studies indexed under Glaucoma.
Browse Glaucoma studies →Optovue is the lead sponsor of 16 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Volunteers with various ocular pathology or no ocular pathology
Exclusion Criteria:
Normal results from the clinical exam and free of ocular pathology.
Clinical exam results consistent with glaucoma; visual field defects consistent with glaucoma and/or structural damage consistent with glaucoma.
Clinical exam results consistent with retina pathology.
Retina measurement
Time frame: at time of study visit (day 1)
This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Optovue